TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35834812

Group type: EXPERIMENTAL
Intervention: 30 μg HPV‐6/11 vaccine
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: 60 μg HPV‐6/11 vaccine
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: 90 μg HPV‐6/11 vaccine
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo vaccine
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: HPV‐6/11 vaccine (all doses)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: HPV‐6/11 vaccine
Number of subjects: 145
Study: 33028649

Group type: EXPERIMENTAL
Intervention: Ironbark group-based fall prevention programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group-based social programme (Control)
Number of subjects: 0
Study: 33774140

Group type: EXPERIMENTAL
Intervention: Treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 35319270

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Duloxetine (OLE)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (OLE)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Newly enrolled patients (OLE)
Number of subjects: 74
Study: 33809062

Group type: EXPERIMENTAL
Intervention: LMF-HSFx
Number of subjects: 42
Study: 35241271

Group type: EXPERIMENTAL
Intervention: Initial opioid prescription for low-pain procedures
Number of subjects: 912121

Group type: EXPERIMENTAL
Intervention: Initial opioid prescription for moderate-pain procedures
Number of subjects: 912121

Group type: EXPERIMENTAL
Intervention: Initial opioid prescription for high-pain procedures
Number of subjects: 912121

Group type: COMPARATOR
Intervention: Sustained opioid use (4-90 days postprocedure)
Number of subjects: 912121
Study: 32921508

Group type: EXPERIMENTAL
Intervention: Auricular acupressure with magnetic beads for 14 days
Number of subjects: 47

Group type: COMPARATOR
Intervention: Blank patches (Control)
Number of subjects: 47
Study: 36469808

Group type: EXPERIMENTAL
Intervention: WiseApp intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Attention control intervention
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Secondary outcomes
Number of subjects: 200
Study: 33854301

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg bolus before induction, followed by 2.0 mg/kg/h until end of operation)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 70
Study: 35896015

Group type: EXPERIMENTAL
Intervention: Video consultation (telemedicine group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: In-person consultation (control group)
Number of subjects: 60
Study: 33989786

Group type: EXPERIMENTAL
Intervention: Physician burden ratings
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Clinical impressions (trust in pain report, medical attribution)
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Management concerns (opioid abuse risk)
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: High medical evidence
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Higher pain severity
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Burden ratings
Number of subjects: 585
Study: 32162816

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 98

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 98
Study: 35346274

Group type: EXPERIMENTAL
Intervention: Interlaminar full-endoscopic discectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional microscopic discectomy
Number of subjects: 100
Study: 33764005

Group type: EXPERIMENTAL
Intervention: Coming back to existence caring model
Number of subjects: 66
Study: 32865010

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC, 4 × 5-min 220-mmHg unilateral occlusion at the thigh muscle)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham intervention (sham, 4 × 5 min 20-mmHg)
Number of subjects: 15
Study: 34851799

Group type: EXPERIMENTAL
Intervention: Tocilizumab 162 mg subcutaneously
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 32664369

Group type: EXPERIMENTAL
Intervention: Disease risk information
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Myth busting information
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control information
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: TPB constructs (Attitudes)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: TPB constructs (Subjective norms)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: TPB constructs (Perceived behavioural control)
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: TPB constructs overall
Number of subjects: 282
Study: 36476354

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Reiki
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control
Number of subjects: 156
Study: 32914403

Group type: EXPERIMENTAL
Intervention: Three-dimensional echocardiography (3DE)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Cardiac magnetic resonance (CMR)
Number of subjects: 85
Study: 33084901

Group type: EXPERIMENTAL
Intervention: Wingman-Connect program
Number of subjects: 1485

Group type: COMPARATOR
Intervention: Stress management program
Number of subjects: 1485
Study: 35436816

Group type: EXPERIMENTAL
Intervention: Oral rivaroxaban (10mg or 15mg)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Subcutaneous enoxaparin (40mg or 60mg)
Number of subjects: 230
Study: 34166841

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (Eligard)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 35430239

Group type: EXPERIMENTAL
Intervention: Customized 3D printed pillbox
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Customized off‐the‐shelf pillbox
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard‐of‐care pillbox
Number of subjects: 15
Study: 33838763

Group type: EXPERIMENTAL
Intervention: Diet self-efficacy
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Higher stress
Number of subjects: 166
Study: 33962340

Group type: EXPERIMENTAL
Intervention: Forearm IVRA
Number of subjects: 280

Group type: COMPARATOR
Intervention: Upper arm IVRA
Number of subjects: 280
Study: 32143221

Group type: EXPERIMENTAL
Intervention: Modified Constraint-Induced Movement Therapy (mCIMT)
Number of subjects: 24
Study: 35533340

Group type: EXPERIMENTAL
Intervention: Burosumab (0.8 mg/kg every 2 weeks)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Pi/D (conventional therapy)
Number of subjects: 61
Study: 32948386

Group type: EXPERIMENTAL
Intervention: Pharmacomechanical catheter‐directed thrombolysis (PCDT)
Number of subjects: 317
Study: 35409861

Group type: COMPARATOR
Intervention: Postoperative co-amoxiclav (625 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Preoperative co-amoxiclav (625 mg) plus postoperative metronidazole (500 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Preoperative co-amoxiclav (625 mg) plus postoperative amoxicillin (500 mg)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 46
Study: 33795621

Group type: EXPERIMENTAL
Intervention: Auditory intervention for laparoscopic cholecystectomy and radical gastrectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both auditory and visual stimulation for colon cancer patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no auditory or visual intervention)
Number of subjects: 0
Study: 32869472

Group type: EXPERIMENTAL
Intervention: Chitosan with whole raw soybean (WRS)
Number of subjects: 4
Study: 35781804

Group type: EXPERIMENTAL
Intervention: IPE 2.0 g/day (1×1 g twice daily) for 28 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: IPE 4.0 g/day (2×1 g twice daily) for 28 days
Number of subjects: 24
Study: 32968914

Group type: EXPERIMENTAL
Intervention: Coloshield
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (without Coloshield)
Number of subjects: 22
Study: 35510617

Group type: EXPERIMENTAL
Intervention: 0.1% fluoride varnish applied in test group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (water) applied in control group
Number of subjects: 42
Study: 32930104

Group type: EXPERIMENTAL
Intervention: Varicocele repair in TA group
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Varicocele repair in NTA group
Number of subjects: 141

Group type: COMPARATOR
Intervention: Comparison of TA and NTA groups
Number of subjects: 141

Group type: COMPARATOR
Intervention: Total motile count (TMC) and DFI in NTA group
Number of subjects: 141
Study: 34167878

Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 129

Group type: COMPARATOR
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 129
Study: 33840803

Group type: EXPERIMENTAL
Intervention: True tDCS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 60
Study: 34578893

Group type: EXPERIMENTAL
Intervention: secukinumab 300 mg
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: secukinumab 300 mg plus a tailored lifestyle intervention program
Number of subjects: 768
Study: 33518733

Group type: EXPERIMENTAL
Intervention: Flatfoot group at slow, normal, and fast gait speeds
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flatfoot group at slow speed
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flatfoot group at fast speed
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups at different gait speeds
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal foot posture group at slow, normal, and fast gait speeds
Number of subjects: 60
Study: 34119426

Group type: EXPERIMENTAL
Intervention: Lateral supraclavicular approach
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional transcervical approach
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 180
Study: 32798079

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 50
Study: 35788069

Group type: EXPERIMENTAL
Intervention: Melatonin supplementation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 34280356

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 UI by mouth once a week)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 32738817

Group type: EXPERIMENTAL
Intervention: Electroacupuncture treatment for stress urinary incontinence
Number of subjects: 384
Study: 34581002

Group type: COMPARATOR
Intervention: MTPS9579A (dissociating anti-tryptase antibody) administered subcutaneously (s.c.) or intravenously (i.v.) in single and multiple ascending doses.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: MTPS9579A
Number of subjects: 106
Study: 34797296

Group type: EXPERIMENTAL
Intervention: Shaobei injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rubber band ligation
Number of subjects: 0
Study: 33152708

Group type: EXPERIMENTAL
Intervention: Maintenance olaparib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36368980

Group type: EXPERIMENTAL
Intervention: Interactive computer-based tool (CatInfo)
Number of subjects: 134
Study: 33557701

Group type: EXPERIMENTAL
Intervention: CO2 laser extirpation with methyl aminolevulinate photodynamic therapy
Number of subjects: 100
Study: 35294595

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC) performed by trained personnel, consisting of four cycles of limb ischemia (4-min via cuff inflation) followed by reperfusion (4-min via cuff deflation), repeated on two consecutive days post randomization.
Number of subjects: 78

Group type: COMPARATOR
Intervention: No remote ischemic conditioning (no-RIC) as control group, continuing standard management of NEC.
Number of subjects: 78
Study: 32857442

Group type: EXPERIMENTAL
Intervention: Maternal knowledge about child development and caregiving
Number of subjects: 1277

Group type: EXPERIMENTAL
Intervention: Maternal engagement in stimulating activities with the child
Number of subjects: 1277
Study: 36239563

Group type: EXPERIMENTAL
Intervention: Active Cycle of Breathing Technique (ACBT) with Watson's Theory of Human Caring
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine care group
Number of subjects: 64
Study: 34657371

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 130/0.4 (HES) at 10 mL/kg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Hypertonic saline 7.5% (HS) at 4 mL/kg
Number of subjects: 23

Group type: COMPARATOR
Intervention: Comparison between HES and HS
Number of subjects: 23
Study: 32538466

Group type: EXPERIMENTAL
Intervention: Fluconazole 5 mg kg‐1 per day
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Griseofulvin 10 mg kg‐1 per day
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Itraconazole 5 mg kg‐1 per day
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Terbinafine 7·5 mg kg‐1 per day
Number of subjects: 200
Study: 34238688

Group type: EXPERIMENTAL
Intervention: 19 Gy single-fraction HDR brachytherapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Iodine-125 Low-Dose-Rate brachytherapy
Number of subjects: 31
Study: 34033513

Group type: EXPERIMENTAL
Intervention: RehaCom rehabilitation software (ten 45‐min sessions across five weeks, two sessions per week)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 50
Study: 32272962

Group type: EXPERIMENTAL
Intervention: Digitally collected patient-reported outcome measures (PROMs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care without PROMs
Number of subjects: 0
Study: 32657670

Group type: EXPERIMENTAL
Intervention: Antrodia cinnamomea mycelium (ACM), 420 mg, three capsules per day for 6 months
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (starch), 420 mg, three capsules per day for 6 months
Number of subjects: 28
Study: 32489001

Group type: EXPERIMENTAL
Intervention: tongue‐hold swallowing
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: tongue‐pressure resistance training
Number of subjects: 74

Group type: COMPARATOR
Intervention: control group
Number of subjects: 74
Study: 35840352

Group type: EXPERIMENTAL
Intervention: Adaptive Servo Ventilation (ASV)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control (guideline-based medical therapy)
Number of subjects: 312
Study: 34076919

Group type: EXPERIMENTAL
Intervention: brodalumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: ustekinumab
Number of subjects: 0
Study: 34929392

Group type: EXPERIMENTAL
Intervention: Sugarcane bagasse diet (33 g/d fiber)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fiber combination diet (sugarcane bagasse with resistant starch, 45 g/d fiber)
Number of subjects: 26
Study: 33154288

Group type: EXPERIMENTAL
Intervention: Audio-visual aid and face-to-face interactive sessions
Number of subjects: 166

Group type: COMPARATOR
Intervention: Pamphlets alone
Number of subjects: 166
Study: 36262203

Group type: EXPERIMENTAL
Intervention: Shenqisuxin granule (SQSX) for 2 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo for 2 months
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Shenqisuxin granule (SQSX)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33002647

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy with reduced treatment volumes (50.4 Gy total radiation dose, fluoropyrimidine‐based chemotherapy)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy with reduced treatment volumes
Number of subjects: 52
Study: 35831757

Group type: EXPERIMENTAL
Intervention: Key feature format (test-enhanced learning)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Read-only cases
Number of subjects: 94
Study: 34645411

Group type: EXPERIMENTAL
Intervention: PRO‐ACTIVE EAT (low intensity prophylactic intervention)
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: PRO‐ACTIVE EAT+EXERCISE (high intensity prophylactic intervention)
Number of subjects: 952

Group type: COMPARATOR
Intervention: RE‐ACTIVE (started promptly if/when dysphagia is identified)
Number of subjects: 952

Group type: EXPERIMENTAL
Intervention: Secondary outcomes include objective measures of swallow physiology and function, pneumonia and weight loss, quality of life, symptom burden, and self-efficacy.
Number of subjects: 952
Study: 33232794

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (70 steps per minute)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Housework (at the same intensity as aerobic exercise)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (sedentary)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Housework
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study: 35606229

Group type: EXPERIMENTAL
Intervention: Structured exercise program for 3 days a week over 6 weeks (T1-T2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Structured exercise program for 3 days a week over 6 weeks (T2-T3)
Number of subjects: 30
Study: 33650767

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) session per month and three home exercise sessions per week for four months
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 19
Study: 32060991

Group type: EXPERIMENTAL
Intervention: Operant conditioning
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 0
Study: 33947363

Group type: EXPERIMENTAL
Intervention: Ibandronate treatment for osteoporosis alone (Group 1)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Ibandronate treatment for osteoporosis with symptomatic LSS (Group 2)
Number of subjects: 159
Study: 33176700

Group type: EXPERIMENTAL
Intervention: Unassisted HIV self-testing (UH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Directly assisted HIV self-testing (DAH)
Number of subjects: 0
Study: 34742917

Group type: EXPERIMENTAL
Intervention: Multi-interventional approach for medication safety (MIMS) including medication reconciliation at admission and discharge, medication review, and standardized transmission of medication changes to community practitioners.
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual approach applied in the AGU (control group).
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Multi-interventional approach for medication safety (MIMS)
Number of subjects: 109
Study: 34073277

Group type: EXPERIMENTAL
Intervention: Care management intervention
Number of subjects: 268

Group type: COMPARATOR
Intervention: Attention control telephone intervention
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 268
Study: 36100725

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RECO) applied by inflating/deflating (200/0 mmHg for 5/5 min) 4 times a cuff around an arm every 12 h for 24 h
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard care (sham procedure)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RECO)
Number of subjects: 180
Study: 35170724

Group type: EXPERIMENTAL
Intervention: Hypnosis and self-hypnosis (8 sessions) combined with standard nutritional education (8 workshops)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard nutritional education (8 workshops)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Hypnosis and self-hypnosis
Number of subjects: 82
Study: 34550939

Group type: EXPERIMENTAL
Intervention: Michigan Hand Outcomes Questionnaire
Number of subjects: 0
Study: 33393650

Group type: EXPERIMENTAL
Intervention: SpiroTimer™
Number of subjects: 52
Study: 33876525

Group type: EXPERIMENTAL
Intervention: 3-month structured bronchoscopy curriculum with simulator training
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional apprenticeship training
Number of subjects: 18
Study: 32178928

Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 109

Group type: COMPARATOR
Intervention: General anesthesia with inhaled anesthetic
Number of subjects: 109

Group type: COMPARATOR
Intervention: Total intravenous anesthesia
Number of subjects: 109
Study: 34979544

Group type: EXPERIMENTAL
Intervention: 24 IU of intranasal oxytocin (IN-OT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 19
Study: 33742783

Group type: EXPERIMENTAL
Intervention: Population pharmacokinetic (PopPK) approach
Number of subjects: 100

Group type: COMPARATOR
Intervention: Noncompartmental analysis (NCA) approach
Number of subjects: 100
Study: 33446373

Group type: EXPERIMENTAL
Intervention: Ultrasound bladder vibrometry (UBV) in supine position
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ultrasound bladder vibrometry (UBV) in sitting position
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ultrasound bladder vibrometry (UBV) in both positions
Number of subjects: 8
Study: 32519235

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive (SE)
Number of subjects: 1120

Group type: EXPERIMENTAL
Intervention: Universal adhesive (U)
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1120
Study: 35879015

Group type: EXPERIMENTAL
Intervention: Bariatric surgery and intensive goal-directed medical therapy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Bariatric surgery and standard medical care
Number of subjects: 150
Study: 33504953

Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily)
Number of subjects: 1879

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1879
Study: 32194251

Group type: EXPERIMENTAL
Intervention: Slow-release oral morphine (SROM)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 298
Study: 35367059

Group type: EXPERIMENTAL
Intervention: Conventional Morphological Assessment (CMA)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Time-Lapse Monitoring (TLM)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Fresh Embryo Transfer (CMA)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Fresh Embryo Transfer (TLM)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Frozen Embryo Transfer (CMA)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Frozen Embryo Transfer (TLM)
Number of subjects: 139